Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipoprotein apheresis as rescue therapy in lipoprotein glomerulopathy: The role of plasmatic extracellular vesicle removal.

Journal of clinical lipidology - 1 Jul 2026

Sampietro Tiziana, Sbrana Francesco, Dal Pino Beatrice, Migliori Massimiliano, Bruno Stefania, Grange Cristina, Bussolati Benedetta, Camussi Giovanni, Grossini Elena, Bigazzi Federico, Viacava Paolo, Panichi Vincenzo, Cantaluppi Vincenzo

Abstract excerpt

BACKGROUND: Lipoprotein glomerulopathy (LPG) is a rare disease affecting the kidney, clinically characterized by type III hyperlipoproteinemia, mutated apolipoprotein E (ApoE), the presence of glomerular lipoprotein thrombi, proteinuria in the nephrotic range, and progression toward chronic kidney disease (CKD). OBJECTIVE: Evaluate the role of lipoprotein apheresis (LA) as rescue therapy in LPG. METHODS: Since...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to Blood Component Removal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Extracellular Vesicles

Share to Kidney Diseases

Share to Lipoproteins

Share to Mutation

Share to Nephrotic Syndrome

Share to Podocytes

Source

Identifiers

PMID: 42168057
DOI: 10.1016/j.jacl.2026.04.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 15 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipoprotein apheresis as rescue therapy in lipoprotein glomerulopathy: The role of plasmatic extracellular vesicle removal.PMID 42168057Read ↗

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.Semantic proximity Read ↗

[Therapeutic apheresis in idiopathic nephrotic syndrome].Semantic proximity Read ↗

Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels.Semantic proximity Read ↗

High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.Semantic proximity Read ↗

The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.Semantic proximity Read ↗

Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods.Semantic proximity Read ↗

Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese patient with lipoprotein glomerulopathy.Semantic proximity Read ↗

Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort.Semantic proximity Read ↗

Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.Semantic proximity Read ↗

Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.Semantic proximity Read ↗

Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.Semantic proximity Read ↗

A rare cause of nephrotic syndrome: lipoprotein glomerulopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.